TriSalus Life Sciences(TLSI) - 2020 Q4 - Annual Report

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 Registrant's telephone number, including area code: (908) 391-1288 For the transition period from to Securities registered pursuant to Section 12(b) of the Act: Commission file number: 001-39813 | ...